- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02973334
Acute Effects of Artificial Sweeteners or Sugar on Hemodynamic and Metabolic Stress Responses (EduStress)
Acute Effects of Artificial Sweeteners' or Sugar's Ingestion on Hemodynamic and Metabolic Stress Response: An Exploratory, Randomized, Cross-over Trial in Healthy Young Women.
Study Overview
Status
Conditions
Detailed Description
This single-center study included five visits. The first two visits (screening and familiarization) allowed checking the eligibility of the volunteers. In case of inclusion, the subjects were assigned to a sequence of three experimental conditions (water, sugar and artificial sweeteners), in a randomized, crossover design.
The experimental test was divided into 5 stages:
- a 90 minutes baseline period (t=0-90 min),
- a 30-min mental stress (MS; t=90-120 min), consisting in 5-min periods of Stroop's color word conflict test alternated with 5-min periods of mental arithmetic test.
- a 30-min MS recovery period (t=120-150),
- a 3-min cold pressure test (CPT) was carried out, aiming at immersing one volunteer's forearm in an ice water container at 3°C,
3) a 15-min CPT recovery period (t=120-150). 60 min after the beginning of the metabolic test, volunteers will drink 25 mL every 15 min, after 10-sec mouth rinsing, of either an artificially- or sugar-sweetened beverages or water (control).
Hemodynamic stress responses will be measured by repeated blood pressure, heart rate and cardiac output. Repeated venous blood samples will allow to assess metabolic stress responses.
Each condition (water, artificial sweeteners and sugar) will be preceded by a 2-day run-in period.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Lausanne, Switzerland, 1005
- University of Lausanne
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Healthy
- Caucasian
- Normal Body Mass Index (18.5 ≤BMI≤ 25 kg/m2)
- Monophasic oral contraceptive
Exclusion Criteria:
- Hypertension (Blood pressure >140/90 mmHg)
- History or actual psychologic/cardiovascular troubles
- Anemia anamnesis
- Being Pregnant
- Weight < 50 kg
- Blood donation or participation to another study < 8 weeks
- Claustrophobia
- Consumption of sugar/artifically-sweetened beverages drinks > 5 dL/d
- Visual disturbances (daltonism)
- Low to moderate physical activity (> 4h/wk)
- Smoker and narcotic consumption
- Caffeine (> 400 mg/d) and/or alcohol (> 10g/d) consumption
- Medical treatment
- Weight variation > 3kg during the last month
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Sugar
Effects of ingestion of sugar-sweetened beverages on acute stress response
|
From t=60 to the end of the metabolic test, volunteers will ingest 7 beverages containing sugar (25 mL / beverage) every 15 minutes after 10-sec mouth rinsing.
|
|
Experimental: Artificial sweetener
Effects of ingestion of artificially-sweetened beverages on acute stress response
|
From t=60 to the end of the metabolic test, volunteers will ingest 7 beverages containing non nutritive sweeteners (25 mL / beverage) every 15 minutes after 10-sec mouth rinsing.
|
|
Active Comparator: Water
Effects of ingestion of water on acute stress response
|
From t=60 to the end of the metabolic test, volunteers will ingest 7 water beverages (25 mL / beverage) every 15 minutes after 10-sec mouth rinsing.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hemodynamic changes
Time Frame: Differences observed between 90-min baseline and stress (30-min mental stress and 3-min cold pressure test)
|
Hemodynamic changes elicited by stress will be assessed by means of systemic vascular resistance calculated as (blood flow):(mean arterial pressure, and expressed in arbitrary units
|
Differences observed between 90-min baseline and stress (30-min mental stress and 3-min cold pressure test)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in concentration of blood glucose
Time Frame: Blood samples will be collected 30, 60, 75, 85, 95, 100, 110, 120, 125, 135, 145, 153, 158, and 163 minutes after the beginning of the test
|
Blood glucose concentration will be measured in fasting conditions and during stress tests with the glucose oxidase method and expressed in mg/dl
|
Blood samples will be collected 30, 60, 75, 85, 95, 100, 110, 120, 125, 135, 145, 153, 158, and 163 minutes after the beginning of the test
|
|
Changes in concentration of blood insulin
Time Frame: Blood samples will be collected 30, 60, 75, 85, 95, 100, 110, 120, 125, 135, 145, 153, 158, and 163 minutes after the beginning of the test
|
Blood insulin concentration will be measured by ELISA and expressed in mU/L
|
Blood samples will be collected 30, 60, 75, 85, 95, 100, 110, 120, 125, 135, 145, 153, 158, and 163 minutes after the beginning of the test
|
|
Changes in blood non-esterified fatty acid concentration
Time Frame: Blood samples will be collected 30, 60, 75, 85, 95, 100, 110, 120, 125, 135, 145, 153, 158, and 163 minutes after the beginning of the tes
|
Blood non-esterified fatty acid concentration will be measured by a colorimetric method and expressed in mmol/L
|
Blood samples will be collected 30, 60, 75, 85, 95, 100, 110, 120, 125, 135, 145, 153, 158, and 163 minutes after the beginning of the tes
|
|
Metabolic changes
Time Frame: Differences observed between 90-min baseline and stress (30-min mental stress and 3-min cold pressure test)
|
Metabolic changes elicited by stress will be continually monitored from respiratory gas exchanges by indirect calorimetry.
|
Differences observed between 90-min baseline and stress (30-min mental stress and 3-min cold pressure test)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Luc Tappy, Professor, Department of Physiology, University of Lausanne, Switzerland
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 316/15
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Normal Subjects
-
Temple UniversityCompleted
-
University Hospital, AngersInstitut de Formation en Education Physique et en Sport d'Angers/Les Ponts...Completed
-
Yonsei UniversityEnrolling by invitation
-
University of California, DavisCompletedNormal SubjectsUnited States
-
Universidade Federal de PernambucoCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.; Conselho Nacional... and other collaboratorsCompleted
-
Halia Therapeutics, Inc.TKL Research, Inc.Completed
-
Schiefer UlrichCompletedOphthalmologically Normal SubjectsGermany
-
Taiwan Liposome CompanyCompleted
-
Amen Clinics, Inc.CompletedNormal Human SubjectsUnited States
-
Halia Therapeutics, Inc.Completed
Clinical Trials on Ingestion of sugar-sweetened beverages
-
Instituto de Nutrición y Tecnología de los AlimentosUnknown
-
University of TorontoCanadian Institutes of Health Research (CIHR)CompletedCardiovascular Diseases | Hypertension | Healthy | Obesity | Diabetes | Overweight | Metabolic Syndrome | PreDiabetes | Overweight and Obesity | Cardiovascular Risk Factor | DysglycemiaCanada
-
University of California, DavisNational Heart, Lung, and Blood Institute (NHLBI); Touro University, CaliforniaCompletedMetabolic Syndrome | Cardiovascular Risk Factor | Insulin Sensitivity | Type2 Diabetes MellitusUnited States
-
University of California, MercedNational Cancer Institute (NCI)CompletedNutrition | Lifestyle-related Condition | Sugar Sweetened Beverage Consumption | Lifestyle Risk ReductionUnited States
-
Harvard UniversityCompleted
-
Fred Hutchinson Cancer CenterNational Heart, Lung, and Blood Institute (NHLBI); University of WashingtonCompletedObesity | Cardiovascular Disease | Type 2 Diabetes Mellitus | Intestinal Permeability | Low-grade Chronic InflammationUnited States
-
John SievenpiperCanadian Institutes of Health Research (CIHR); Canada Research Chairs Endowment... and other collaboratorsUnknownObesity | Diabetes | Overweight | Metabolic Syndrome | Prediabetes | DysglycemiaCanada
-
Provident Clinical ResearchBioFortis; Dairy Research InstituteCompletedDiabetesUnited States
-
Duke UniversityCompleted